Federal award
REJUVENATE BIO INC.
H9240520C0004
ContractSBIR/STTR SR2
Obligated and Ceiling
- Obligated (net)
- $1,445,046.00
- Ceiling (potential value, not spending)
- $1,445,046.00
- Current value
- $1,445,046.00
- Gross positive obligations
- $1,445,046.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- REJUVENATE BIO INC. · GEKFSVSTKK55
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- REJUVENATE BIO INC. · GEKFSVSTKK55
- Awarding agency
- Department of War · sub-agency 9763 · office S0514A
- Funding agency
- Department of War · sub-agency 97ZS
- Product or service (PSC)
- AZ13 · R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT)
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- H9240520C0004
- Award type code
- D
- Actions
- 6 · Dec 5, 2019 to Mar 8, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 8, 2023 | FY2023 | ARZ997 | W | $0.00 | — |
| May 26, 2022 | FY2022 | P00004 | M | $0.00 | — |
| Aug 17, 2020 | FY2020 | P00003 | C | $695,046.00 | — |
| Apr 17, 2020 | FY2020 | P00002 | B | $0.00 | — |
| Feb 11, 2020 | FY2020 | P00001 | C | $350,000.00 | — |
| Dec 5, 2019 | FY2020 | 0 | — | $400,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.